Here’s How Much the Definition of Middle Class Has Changed in the South
Trying to define the middle class in any region can be a tricky task, as it's not necessarily based just on salary, but also ...
Clough Global Equity Fund Section 19(a) Notice
Statement Pursuant to Section 19(a) of the Investment Company Act of 1940 DENVER, CO / ACCESS Newswire / March 31, 2025 / On ...
Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign
Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® ...
Kremlin says US companies have shown initial interest in Russian rare earth projects
The Kremlin said on Monday that some Americans companies had shown interest in joint rare earth metals projects in Russia, ...
ROYC and BCG: Capturing Wealth Management’s $3 Trillion Private Market Opportunity
Private market assets under management (AuM) have been growing at over 10% a year, across private equity, venture capital, ...
Upstream Festival The Netherlands 2025: Everything Startups and Scale-Ups Need to Grow
On 21 and 22 May 2025, Upstream Festival returns, bringing together everything startups need to grow. More than 45 partners ...
TJC Closes Acquisition of L3Harris’ Commercial Aviation Solutions Business
TJC, L.P. ("TJC"), announced today that an affiliate of The Resolute Fund VI, L.P. ("Resolute VI") has closed the acquisition ...
Dimension Hospitality Expands Their Portfolio by adding a Hilton in Alabama
Dimension Hospitality grows its geography and expands its portfolio by welcoming the Homewood Suites by Hilton Mobile Airport ...
IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications
Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that the National Medical Products Administration (NMPA) of ...
Driven Brands Holdings Among 3 Stocks Priced Below Estimated Fair Value
Amid recent market volatility, driven by concerns over new tariffs and economic data, investors are keenly observing stocks that may be undervalued in the current climate. Identifying stocks priced ...
AvaSure Acquires Nurse Disrupted to Advance Clinically-Developed Virtual Nursing Across Care Settings
AvaSure, the leader in AI-powered virtual care solutions, today announced the acquisition of Nurse Disrupted, a nurse-founded virtual nursing platform designed to enhance care delivery across both ...